Search Results - "ANSIAUX, Réginald"
-
1
Thalidomide Radiosensitizes Tumors through Early Changes in the Tumor Microenvironment
Published in Clinical cancer research (15-01-2005)“…Purpose: The aim of this work was to study changes in the tumor microenvironment early after an antiangiogenic treatment using thalidomide (a promising…”
Get full text
Journal Article Web Resource -
2
Use of botulinum toxins in cancer therapy
Published in Expert opinion on investigational drugs (01-02-2007)“…A recent study has demonstrated for the first time that botulinum neurotoxin (BoNT) briefly opens tumour vessels, allowing more effective destruction of cancer…”
Get more information
Journal Article -
3
Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy
Published in Cancer research (Chicago, Ill.) (01-10-2006)“…Emerging preclinical studies support the concept of a transient "normalization" of tumor vasculature during the early stage of antiangiogenic treatment, with…”
Get full text
Journal Article Web Resource -
4
Caveolin-1 Is Critical for the Maturation of Tumor Blood Vessels through the Regulation of Both Endothelial Tube Formation and Mural Cell Recruitment
Published in The American journal of pathology (01-11-2007)“…In the normal microvasculature, caveolin-1, the structural protein of caveolae, modulates transcytosis and paracellular permeability. Here, we used…”
Get full text
Journal Article -
5
Potentiation of cyclophosphamide chemotherapy using the anti-angiogenic drug thalidomide: Importance of optimal scheduling to exploit the ‘normalization’ window of the tumor vasculature
Published in Cancer letters (28-11-2006)“…The aim of this work was to study how administration schedule affects potentiation of cyclophosphamide, an alkylating agent, by thalidomide, an anti-angiogenic…”
Get full text
Journal Article Web Resource -
6
The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2-weighted GRE signal within tumors
Published in NMR in biomedicine (01-02-2006)“…Acute hypoxia (transient cycles of hypoxia‐reoxygenation) is known to occur in solid tumors and is generally believed to be caused by tumor blood flow…”
Get full text
Journal Article -
7
Complex relationship between changes in oxygenation status and changes in R 2: The case of insulin and NS-398, two inhibitors of oxygen consumption
Published in Magnetic resonance in medicine (01-09-2006)“…Insulin and NS‐398 have been reported to inhibit oxygen consumption in experimental tumor models, thereby increasing oxygenation and radiosensitization. The…”
Get full text
Journal Article -
8
19F NMR in vivo spectroscopy reflects the effectiveness of perfusion-enhancing vascular modifiers for improving gemcitabine chemotherapy
Published in Magnetic resonance in medicine (01-01-2008)“…Nuclear magnetic resonance spectroscopy of fluorine‐19 (19F NMR) has proven useful for evaluating kinetics of fluorinated chemotherapy drugs in tumors in vivo…”
Get full text
Journal Article -
9
Complex relationship between changes in oxygenation status and changes in R : The case of insulin and NS‐398, two inhibitors of oxygen consumption
Published in Magnetic resonance in medicine (01-09-2006)“…Abstract Insulin and NS‐398 have been reported to inhibit oxygen consumption in experimental tumor models, thereby increasing oxygenation and…”
Get full text
Journal Article -
10
The role of vessel maturation and vessel functionality in spontaneous fluctuations ofT2-weighted GRE signal within tumors
Published in NMR in biomedicine (01-02-2006)Get full text
Journal Article -
11
Early reoxygenation in tumors after irradiation: determining factors and consequences for radiotherapy regimens using daily multiple fractions
Published in International journal of radiation oncology, biology, physics (01-11-2005)“…To characterize changes in the tumor microenvironment early after irradiation and determine the factors responsible for early reoxygenation. Fibrosarcoma type…”
Get more information
Journal Article -
12
Botulinum toxin potentiates cancer radiotherapy and chemotherapy
Published in Clinical cancer research (15-02-2006)“…PURPOSE: Structural and functional abnormalities in the tumor vascular network are considered factors of resistance of solid tumors to cytotoxic treatments. To…”
Get full text
Journal Article Web Resource -
13
Decrease in Tumor Cell Oxygen Consumption after Treatment with Vandetanib (ZACTIMA™; ZD6474) and its Effect on Response to Radiotherapy
Published in Radiation research (01-11-2009)“…We investigated the early effects of vandetanib (ZACTIMA™; ZD6474), an inhibitor of VEGFR-dependent angiogenesis, on tumor oxygenation and on the possible…”
Get full text
Journal Article -
14
Physiological noise in murine solid tumours using T2-weighted gradient-echo imaging: a marker of tumour acute hypoxia?
Published in Physics in medicine & biology (07-08-2004)“…T2*-weighted gradient-echo magnetic resonance imaging (T2*-weighted GRE MRI) was used to investigate spontaneous fluctuations in tumour vasculature…”
Get more information
Journal Article -
15
Complex relationship between changes in oxygenation status and changes in R2: the case of insulin and NS-398, two inhibitors of oxygen consumption
Published in Magnetic resonance in medicine (01-09-2006)“…Insulin and NS-398 have been reported to inhibit oxygen consumption in experimental tumor models, thereby increasing oxygenation and radiosensitization. The…”
Get full text
Journal Article -
16
19 F NMR in vivo spectroscopy reflects the effectiveness of perfusion‐enhancing vascular modifiers for improving gemcitabine chemotherapy
Published in Magnetic resonance in medicine (01-01-2008)“…Abstract Nuclear magnetic resonance spectroscopy of fluorine‐19 ( 19 F NMR) has proven useful for evaluating kinetics of fluorinated chemotherapy drugs in…”
Get full text
Journal Article -
17
Decrease in Tumor Cell Oxygen Consumption after Treatment with Vandetanib (ZACTIMA(TM); ZD6474) and its Effect on Response to Radiotherapy
Published in Radiation research (01-11-2009)“…We investigated the early effects of vandetanib (ZACTIMA(TM); ZD6474), an inhibitor of VEGFR-dependent angiogenesis, on tumor oxygenation and on the possible…”
Get full text
Journal Article